buprenorphine

(redirected from Butrans)
Also found in: Medical.

bu·pre·nor·phine

 (byo͞o′prə-nôr′fēn′)
n.
A semisynthetic opioid drug, C29H41NO4, used usually in its hydrochloride form as an analgesic and, in combination with naloxone, for long-term treatment of addiction to opioids such as heroin.

[bu(tyl) + pr(opyl) + en(do-) or (eth)en(e) + (m)orphine.]

buprenorphine

(bjuːˈprɛnɔːfiːn)
n
(Medicine) an opiate used medicinally as a powerful analgesic
Translations

buprenorphine

n buprenorfina
Mentioned in ?
References in periodicals archive ?
They also took noncontrolled drugs including Butrans which are used for pain relief and psychostimulants for treatment of conditions such as ADHD.
com)-- American Clinical Solutions is going to launch a new testing service for BuTrans (buprenorphine) in urine samples soon.
While hailed as a great advance in pain management, the BuTrans patch has also proven to be a challenge for monitoring compliance.
127) For example, the FDA approved Butrans (buprenorphine), an opioid administered through a patch placed on the patient's skin for managing moderate to severe chronic pain.
Because opioids are associated with adverse drug events that the FDA believes cannot be mitigated by less burdensome strategies, the FDA has approved opioids such as Butrans with a REMS containing ETASUs.
In 2010, the FDA approved Butrans, an extended-release buprenorphine patch (Purdue Pharma), in 5-, 10- and 20-mcg/hour doses.
An investigation is now under way at the Lloyds pharmacy in Riley Square, Bell Green, where the medication was sent from to determine how the error was made The prescription of BuTrans, which in high doses is potentially lethal, was mistakenly posted by a Lloyds pharmacy delivery driver through the door of her home in Wappenbury Road, last Thursday.
Julie was visibly shaken when she recalled the moment she found her son playing with the random prescription packet of BuTrans patches which contain buprenorphine, a strong painkiller related to morphine.
ST MIRREN'S Under-16 team lost 6-4 to Butrans of Hungary in the final of the Atletico Nuoro Tournament in Sardinia.
The featured studies evaluated the safety and efficacy of Butrans in a variety of patient scenarios.
The FDA approved the product, marketed as Butrans transdermal system CIII by Purdue Pharma LR last month.
Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.